JSE firms amid tech stock losses and Covid-19 vaccine setback
Some investors see the latest downturn as a healthy correction after several of the tech giants reached staggering heights, one analyst says
09 September 2020 - 12:41
The JSE was firmer on Wednesday along with European markets, as investors shrug off concerns over tech stocks losses and a Covid-19 vaccine candidate.
European shares shrugged off heavy losses for US tech stocks on Wednesday, while major drugmaker AstraZeneca delayed testing of a possible coronavirus vaccine, Reuters reported...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.